Responses
Diagnosis
Randomised controlled trial
Single HPV test not useful for predicting CIN2 or worse or for guiding choice of further investigations for women aged 20–59 presenting to NHS Cervical Screening Programme with borderline abnormalities or mild dyskaryosis
Compose a Response to This Article
Other responses
No responses have been published for this article.